Quantcast
Last updated on April 17, 2014 at 10:34 EDT

Latest Sequenom Inc. Stories

2013-10-22 08:32:06

The MaterniT21 PLUS Test Celebrates its Second Anniversary Since Launch SAN DIEGO, Oct. 22, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Center for Molecular Medicine, doing business as Sequenom Laboratories, has launched the Enhanced Sequencing Series for its MaterniT21(TM) PLUS laboratory-developed test (LDT). The MaterniT21 PLUS test...

2013-10-01 08:27:18

NEW YORK, October 1, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Investors' Reports announced new research reports highlighting Cubist Pharmaceuticals Inc. (NASDAQ: CBST), Halozyme Therapeutics, Inc. (NASDAQ: HALO), Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Galena Biopharma, Inc. (NASDAQ: GALE) and Sequenom Inc. (NASDAQ: SQNM). Today's readers may access these reports free of charge - including full...

2013-09-23 16:24:17

Jefferies LLC Engaged as Financial Advisor SAN DIEGO, Sept. 23, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that its Board of Directors has authorized a review of potential strategic alternatives for its Genetic Analysis business segment. The review will include evaluation of a full range of potential strategic alternatives for the Genetic Analysis business segment....

2013-09-18 08:28:34

SAN DIEGO, Sept. 18, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a Certified Service Provider (CSP) program for the technical certification of selected laboratories offering research services using the Sequenom research-use-only MassARRAY(®) System. Certifications cover the major research applications of the MassARRAY System, including iPLEX(®) genotyping,...

2013-09-09 16:24:01

SAN DIEGO, Sept. 9, 2013 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Sequenom, Inc. (NASDAQ: SQNM) breached their fiduciary duties to shareholders. Sequenom provides genetic analysis solutions in the United States and internationally. (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO) Sequenom Stock Drops on Report of Cash Collection Problems On July 24, 2013, Sequenom announced the...

2013-08-29 08:25:33

Editor Note: For more information about this release, please scroll to bottom. LONDON, August 29, 2013 /PRNewswire/ -- The U.S. equity market ended higher on Wednesday, August 28, 2013. The S&P 500 advanced 0.27%, to close the day at 1,634.96. Shares of companies in the biotechnology industry also ended on a higher note, tracking gains in the broader market. The major movers included Inovio Pharmaceuticals Inc. (NYSE MKT: INO), Onyx Pharmaceuticals Inc. (NASDAQ: ONXX),...

2013-08-07 08:28:51

SAN DIEGO, Aug. 7, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Wedbush 2013 Life Sciences Management Access Conference at the Le Parker Meridien in New York, NY on August 13-14, 2013. William Welch, President and COO, and Paul V. Maier, Chief Financial Officer, will present on Tuesday, August 13, 2013, beginning at 8:00 a.m. ET,...

2013-08-05 08:26:56

All Sequenom CMM Laboratory Locations CLIA-Certified and CAP-Accredited with Receipt of CAP Accreditation in North Carolina SAN DIEGO, Aug. 5, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that the New York Department of Health's Wadsworth Center Clinical Laboratory Evaluation Program (CLEP) has issued a clinical laboratory permit to allow the Sequenom Center for Molecular Medicine's...

2013-08-01 08:32:50

Companies to Join Forces to Broaden Market for Comprehensive Prenatal Analyses SAN DIEGO and IRVINE, Calif., Aug. 1, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, and CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics laboratory performing DNA-based testing services for developmental disorders and cancer, today jointly announced that the Sequenom Center for Molecular...

2013-07-24 16:24:30

Continued Growth in Testing Volumes as NIPT Market Leader SAN DIEGO, July 24, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $34.9 million for the second quarter of 2013, an increase of 91% compared to revenues of $18.3 million for the second quarter of 2012. Revenues from the Sequenom CMM diagnostics services operating segment were $24.5 million in the second quarter of...